Delivery Order SPE2DB24D2011-SPE2DB24FBRCX
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XCOPRI 50 MG TABLET 30S. The contract has an ultimate completion date of September 11, 2024 and a ceiling value of $3,413.64. The award is not associated with a set-aside program. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,709.34 firm fixed price contract is for the supply of 30-count tablets of the pharmaceutical product XCOPRI 100 MG. The ultimate completion date is September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the DLA to...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The order has a ceiling value of $3,247.98 and an ultimate completion date of June 26, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order under an Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor, for the supply of 4565952797 - XCOPRI 50 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,823.68 and an ultimate completion date of September 27, 2024. It is not a set-aside contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, under which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of the prescription medication XCOPRI 100 MG TABLET 30S. The $9,635.67 firm fixed-price contract has an ultimate completion date of October 9, 2024. The contract is not associated with a set-aside program. AmerisourceBergen is the prime contractor and will be delivering the pharmaceutical product to support the DLA's medical supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,357.92, is for the supply of XCOPRI 200 MG TABLET 30S, a medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 150 mg tablets. The contract has a ceiling value of $1,082.68 and runs through September 5, 2024. The contract is a Firm Fixed Price type and does not have any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a potential value of $1,082.68 and a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product, with a ceiling value of $2,357.92 and a completion date of November 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has a total ceiling value of $5,916.75 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received an indefinite delivery contract (IDC) from DLA, valued at up to...